Picture of PetIQ logo

PETQ — PetIQ News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

PetIQ Inc reports results for the quarter ended in March - Earnings Summary

* PetIQ Inc  PETQ.OQ  reported quarterly adjusted earnings
of 58
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 45
cents.  The mean expectation of five analysts for the quarter
was for earnings of 43 cents per share. Wall Street expected
results to range from 37 cents to 50 cents per share.
    * Revenue rose 6.2% to $308.44 million from a year ago;
analysts
expected $300.49 million. 
    * The company reported quarterly net income of $14.91
million.
    * PetIQ Inc shares had fallen by 3.4% this quarter and
lost 10.6%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for PetIQ Inc is
$29.00 
This summary was machine generated from LSEG data May 9 at 04:18
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.43           0.58           Beat
 Dec. 31 2023      -0.29          -0.12          Beat
 Sep. 30 2023      0.02           0.42           Beat
 Jun. 30 2023      0.26           0.46           Beat

Recent news on PetIQ

See all news